Copyright
©The Author(s) 2025.
World J Transplant. Sep 18, 2025; 15(3): 101245
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101245
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101245
Table 1 Clinical characteristics of recipients and cardiac donors at the time of transplant, n (%)
Recipients | n = 279 |
Age (years) | 52 ± 13 |
Male sex | 221 (79) |
White | 232 (83) |
Black | 41 (15) |
Hispanic | 4 (2) |
Asian | 2 (1) |
Height (cm) | 175 ± 10 |
Weight (kg) | 86 ± 18 |
BMI (kg/m2) | 28 ± 5 |
Ischemic cardiomyopathy | 107 (38) |
Presence of left ventricular assist device/total artificial heart | 108 (39) |
Donors | |
Age (years) | 34 ± 11 |
Age ≥ 40 years | 86 (31) |
Male sex | 168 (60) |
Height (cm) | 174 ± 10 |
Weight (kg) | 90 ± 22 |
BMI (kg/m2) | 30 ± 8 |
Ischemic time (minute) | 219 ± 64 |
Male recipient/male donor | 154 (55) |
Male recipient/female donor | 67 (24) |
Female recipient/female donor | 44 (16) |
Female recipient/male donor | 14 (5) |
Donor-recipient PHM difference | 1 ± 16 |
PHM difference < -15% | 31 (11) |
Table 2 Clinical outcomes of heart transplant recipients at 1-year and 3-year post-transplant
At transplant | 1-year post transplant (n = 260) | 3-year post-transplant (n = 230) | |
Survival | N/A | 93% | 85% |
Weight (kg) | 86 ± 18 | 88 ± 19 | 91 ± 20a |
Body mass index | 28 ± 5 | 28 ± 5 | 29 ± 6a |
> 30 kg/m2 | 35% | 36% | 40% |
Left ventricular ejection fraction (%) | N/A | 59 ± 5 | 60 ± 6 |
< 50% | N/A | 2% | 2% |
Presence of donor specific antibodies | N/A | 23% | 26% |
Coronary artery vasculopathy | |||
Grade 0 | N/A | 80% | 75% |
Grade 1 | N/A | 16% | 18% |
Grade 2-3 | N/A | 0% | 4% |
Table 3 Hemodynamics by right heart catheterization at 1-year and 3-year post-transplant
1-year post transplant (n = 260) | 3-year post-transplant (n = 224) | |
Right atrial pressure (mm Hg) | 7.2 ± 4.1 | 7.2 ± 4.2 |
< 10 mmHg | 76% | 72% |
10-14 mmHg | 19% | 23% |
≥ 15 mmHg | 5% | 5% |
Systolic PAP (mm Hg) | 31.6 ± 8.5 | 30.7 ± 7.6 |
Diastolic PAP (mm Hg) | 14.0 ± 4.7 | 14.5 ± 5.1 |
Mean PAP (mm Hg) | 21.4 ± 5.8 | 21.3 ± 5.7 |
> 20 mmHg | 52% | 55% |
Pulmonary capillary wedge pressure (mm Hg) | 11.8 ± 4.7 | 12.3 ± 4.7a |
≤ 12 mmHg | 62% | 55% |
13-17 mmHg | 26% | 30% |
≥ 18 mmHg | 12% | 15% |
Cardiac output (L/minute) | 5.9 ± 1.4 | 5.6 ± 1.2 |
Cardiac index (L/minute/m2) | 2.9 ± 0.6 | 2.6 ± 0.5 |
Pulmonary vascular resistance (Wood units) | 1.7 ± 0.7 | 1.7 ± 0.7 |
> 2 Wood units | 27% | 29% |
Table 4 P values for multivariate analysis for correlation between clinical variables and right atrial pressure, mean pulmonary artery pressure, and pulmonary capillary wedge pressure at 1-year and 3-year post transplant
1-year | 3-year | |||||
RAP | Mean PAP | PCWP | RAP | Mean PAP | PCWP | |
Recipient age | 0.524 | 0.318 | 0.485 | 0.927 | 0.054 | 0.720 |
Recipient BMI | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Donor age | 0.022 | 0.057 | 0.017 | 0.288 | 0.591 | 0.168 |
Donor BMI | 0.385 | 0.342 | 0.354 | 0.839 | 0.896 | 0.852 |
Ischemic time | 0.300 | 0.972 | 0.496 | 0.961 | 0.403 | 0.847 |
PHM difference | 0.036 | 0.120 | 0.008 | 0.455 | 0.664 | 0.377 |
Coronary artery vasculopathy | 0.312 | 0.076 | 0.037 | 0.443 | 0.023 | 0.237 |
Donor specific antibodies | 0.337 | 0.803 | 0.519 | 0.086 | 0.114 | 0.041 |
- Citation: Rajagopalan N, Dennis DR, Akhtarekhavari J, Campbell K. Abnormal invasive hemodynamics in heart transplant recipients: A single-center, retrospective study. World J Transplant 2025; 15(3): 101245
- URL: https://www.wjgnet.com/2220-3230/full/v15/i3/101245.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i3.101245